Craven House Capital PLC Acquisition of Loan Portfolio (0486K)
September 16 2016 - 2:32AM
UK Regulatory
TIDMCRV
RNS Number : 0486K
Craven House Capital PLC
16 September 2016
16th September 2016
Craven House Capital Plc
("Craven House" or the "Company")
Acquisition of Loan Portfolio
The Company today announces that it has completed the
acquisition of a portfolio of non-performing loans from a major
South African bank for a total consideration of ZAR 20,000,000
(twenty million South African Rand).
The loans have been acquired a discount to their face value and
are secured, in a senior position, against a portfolio of real
estate assets in South Africa. The Company is bound by
confidentiality requirements to not disclose further details of the
transaction at this stage.
Mark Pajak, Acting Chairman, commented: "We are very pleased to
have negotiated the acquisition of this loan portfolio at a
discount to its face value. The underlying assets offer significant
security in excess of the face value and the investment is in line
with core elements of our strategy; to seek out distressed assets
and complicated restructuring opportunities in our target markets.
The transaction demonstrates our ability and desire to invest at
all levels of the capital structure in order to generate optimal
risk adjusted returns.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
For further information please contact:
Craven House Capital Plc Tel: 020 7002 1027
Mark Pajak
www.Cravenhousecapital.com
SPARK Advisory Partners Tel: 020 3368
Limited 3550
Nominated Adviser
Matt Davis/Mark Brady
www.sparkadvisorypartners.com
SI Capital Tel: 01483 413500
Broker
Nick Emerson
www.sicapital.co.uk
About Craven House Capital
Craven House Capital is a frontier and emerging market focused
merchant bank seeking value oriented long term investments. Craven
House invests in all segments of the capital structure in
partnership with local entrepreneurs and the local business
community. Craven House provides long term patient capital and is
often involved in restructuring, expansion and turn around
investments in crisis and transitioning economies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQEAXNKFAKKEEF
(END) Dow Jones Newswires
September 16, 2016 03:32 ET (07:32 GMT)
Craven House Capital (LSE:CRV)
Historical Stock Chart
From Apr 2024 to May 2024
Craven House Capital (LSE:CRV)
Historical Stock Chart
From May 2023 to May 2024